The team at Bridgefield possesses a 20+ year history of investing in distressed companies and generating superior risk adjusted investment returns. Bridgefield focuses on opportunities across the corporate capital structure and across the distressed cycle to find investments with attractive risk reward ratios. The goal is to provide equity-like returns with credit-like risk and volatility in an uncorrelated fashion.
The team at Bridgefield previously was with Ilex Capital Management. Ilex was a distressed investment firm, primarily investing in distressed securities and corporate restructuring opportunities. Ilex generated annual compounded returns of more than 30% from 2007 through 2013 before the firm was sold. Ilex was a control investor within a number of leading international consumer product, manufacturing, and health care businesses including Gourmet Express, Calgon, and St. Joseph Healthcare among others.
Bridgefield invests capital on behalf of a diverse group of sophisticated institutions and individuals, including endowments, foundations, insurance companies, private banks, fund-of-funds, pensions, family offices and high net worth individuals.